Christopher Norbury All publications ( 25 ) Fischer MA. Tscharke DC. Donohue KB. Truckenmiller ME. Norbury CC. Reduction of vector gene expression increases foreign antigen-specific CD8+ T-cell priming. 2007 Sep. J Gen Virol. 88(Pt 9):2378-86. Elftman MD. Norbury CC. Bonneau RH. Truckenmiller ME. Corticosterone impairs dendritic cell maturation and function. 2007 Oct. Immunology. 122(2):279-90. Reiley WW. Jin W. Lee AJ. Wright A. Wu X. Tewalt EF. Leonard TO. Norbury CC. Fitzpatrick L. Zhang M. Sun SC. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. 2007 Jun 4. J Exp Med. . Zhang B. Ramesh G. Norbury CC. Reeves WB. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. 2007 Jul. Kidney Int. 72(1):37-44. Antonetti DA. Barber AJ. Bronson SK. Freeman WM. Gardner TW. Jefferson LS. Kester M. Kimball SR. Krady JK. LaNoue KF. Norbury CC. Quinn PG. Sandirasegarane L. Simpson IA. JDRF Diabetic Retinopathy Center Group. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. 2006 Sep. Diabetes. 55(9):2401-11. National Eye Institute Norbury CC. Tewalt EF. Upstream toward the "DRiP"-ing source of the MHC class I pathway. 2006 May. Immunity. 24(5):503-6. Truckenmiller ME. Bonneau RH. Norbury CC. Stress presents a problem for dendritic cells: corticosterone and the fate of MHC class I antigen processing and presentation. 2006 May. Brain Behav Immun. 20(3):210-8. Donohue KB. Grant JM. Tewalt EF. Palmer DC. Theoret MR. Restifo NP. Norbury CC. Cross-priming utilizes antigen not available to the direct presentation pathway. 2006 Jun 8. Immunology.. Norbury CC. Drinking a lot is good for dendritic cells. 2006 Apr. Immunology. 117(4):443-51. National Institute of Allergy and Infectious Diseases Reiley WW. Zhang M. Jin W. Losiewicz M. Donohue KB. Norbury CC. Sun SC. Regulation of T cell development by the deubiquitinating enzyme CYLD. 2006 Apr. Nat Immunol. 7(4):411-7. National Institute of Allergy and Infectious Diseases National Center for Research Resources National Cancer Institute Truckenmiller ME. Princiotta MF. Norbury CC. Bonneau RH. Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generation. 2005 Mar. J Neuroimmunol. 160(1-2):48-60. Norbury CC. Basta S. Donohue KB. Tscharke DC. Princiotta MF. Berglund P. Gibbs J. Bennink JR. Yewdell JW. CD8+ T cell cross-priming via transfer of proteasome substrates. 2004 May 28. Science. 304(5675):1318-21. National Institute of Allergy and Infectious Diseases Truckenmiller ME. Norbury CC. Viral vectors for inducing CD8+ T cell responses. 2004 Jun. Expert Opin Biol Ther. 4(6):861-8. Norbury CC. Sigal LJ. Cross priming or direct priming: is that really the question? 2003 Feb. Curr Opin Immunol. 15(1):82-8. National Institute of Allergy and Infectious Diseases Norbury CC. Malide D. Gibbs JS. Bennink JR. Yewdell JW. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. 2002 Mar. Nat Immunol. 3(3):265-71. Chen W. Norbury CC. Cho Y. Yewdell JW. Bennink JR. Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. 2001 Jun 4. J Exp Med. 193(11):1319-26. Wang B. Norbury CC. Greenwood R. Bennink JR. Yewdell JW. Frelinger JA. Multiple paths for activation of naive CD8+ T cells: CD4-independent help. 2001 Aug 1. J Immunol. 167(3):1283-9. National Institute of Allergy and Infectious Diseases Prasad SA. Norbury CC. Chen W. Bennink JR. Yewdell JW. Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells. 2001 Apr 15. J Immunol. 166(8):4809-12. Norbury CC. Princiotta MF. Bacik I. Brutkiewicz RR. Wood P. Elliott T. Bennink JR. Yewdell JW. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo. 2001 Apr 1. J Immunol. 166(7):4355-62. Norbury CC. Tracing the route taken by peptides and major histocompatibility complex class I molecules in presentation of exogenous antigens. 2001. Methods Mol Biol. 156:33-48. Gretz JE. Norbury CC. Anderson AO. Proudfoot AE. Shaw S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. 2000 Nov 20. J Exp Med. 192(10):1425-40. Schubert U. Antón LC. Gibbs J. Norbury CC. Yewdell JW. Bennink JR. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. 2000 Apr 13. Nature. 404(6779):770-4. Yewdell JW. Norbury CC. Bennink JR. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. 1999. Adv Immunol. 73:1-77. Norbury CC. Chambers BJ. Prescott AR. Ljunggren HG. Watts C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. 1997 Jan. Eur J Immunol. 27(1):280-8. Norbury CC. Hewlett LJ. Prescott AR. Shastri N. Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. 1995 Dec. Immunity. 3(6):783-91.